- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05000814
Study of Cost-effectiveness of the Airway Management in Thoracic Surgery
Study of Cost-effectiveness of the Airway Management and Pulmonary Isolation in Thoracic Surgery Using Standard Double Lumen Tubes vs VivaSight-DL
The investigators want to carry out a study to determine the role of Doble Lumen Tubes with built-in camera Viva Sight-DL (VDLT) in thoracic surgery. With this study the investigators want to study and enlarge the information in the different surgical approaches, including robotic surgery.
The objective of this study is report a single-center experience using individual data costs to compare the cost effectiveness of VDLT Viva Sight versus the use of conventional Doble Lumen Tubes (cDLT) together with fiberoptic bronchoscope in patients undergoing thoracic surgery, in order to generate information for future decision making related to both devices.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators want to carry out a comparative clinical study on the use of conventional double-lumen endobronchial tubes (cDLT) or video double-lumen endobronquial tubes Vivasight DL (VDLT) during intubation in thoracic lung resection surgery, to study their possible advantages and disadvantages.
This will be a prospective, single-center cohort study of Thoracic Surgery in which the VivaSight-DL (n = 55 patients) or conventional DLT (n = 55 patients) is used for lung isolation in elderly patients (≥ 18 years), thoracic surgery procedures of the "lung resection" type: wedge resection, transegmental resection, lobectomy, bilobectomy or pneumectomy by the different surgical approaches: VATS, robotic surgery and thoracotomy.
The objective of this study is to find out if the use of VDLT reduces the need for fiberoptic bronchoscope (FBS) to verify the positioning of the endobronchial tube during intubation and intraoperatively. Reducing the need for FBS could improve the quality of care provided to the patient and reduce costs to the hospital.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ruth Martinez Plumed, Medicine
- Phone Number: 34652678215
- Email: ruth.martinez.plumed@gmail.com
Study Contact Backup
- Name: Manuel Granell Gil, Medicine
- Phone Number: 34609232031
- Email: mgranellg@hotmail.com
Study Locations
-
-
-
Valencia, Spain, 46007
- Recruiting
- Ruth Martinez Plumed
-
Contact:
- RUTH MARTINEZ PLUMED
- Phone Number: 652678215
- Email: RUTH.MARTINEZ.PLUMED@GMAIL.COM
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients of legal age (≥18 years).
- Patients who require one-lung collapse in Thoracic Surgery procedures.
Exclusion Criteria:
- Patients with predicted difficult airway.
- Left main bronchus anomalies.
- Previous thoracic surgery.
- BMI> 40.
- Patients with tracheostomy.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
cDLT
patients using conventional double lumen tube for thoracic surgery
|
VDLT versus the use of DLT with fiberoptic bronchoscope
|
|
VDLT
patients using Vivasight DLT for thoracic surgery
|
VDLT versus the use of DLT with fiberoptic bronchoscope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VDLT reduces the use of fiberoptic bronchoscope
Time Frame: 4 years
|
Determine if the use of VivaSight-DL® for lung isolation during lung resections is associated with less need for the use of fiberoptic bronchoscope to check the patient's airway during Thoracic Surgery compared to a conventional double-lumen tube.The cases where VDLT is used and the fiberoptic bronchoscope is necessary will be quantified.
|
4 years
|
|
Costs associated with the use of VDLT
Time Frame: 4 years
|
|
4 years
|
|
Costs associated with the use of cDLT and fiberoptic bronchoscope
Time Frame: 4 years
|
|
4 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ruth Martinez Plumed
- Principal Investigator: Manuel Granell Gil, Professor, Spanish Society of Anesthesia and Critical Care
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.